IFNG and schizophrenia: Though this may suggest that IL-1β and IFN-γ mRNAs increases in schizophrenia are mild to moderate, we would argue that large changes would not necessarily be expected in vivo in medicated patients with schizophrenia who appear to have low-level, subclinical inflammation.